Does BEVACIZUMAB Cause Hepatitis b reactivation? 103 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Hepatitis b reactivation have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.1% of all adverse event reports for BEVACIZUMAB.
103
Reports of Hepatitis b reactivation with BEVACIZUMAB
0.1%
of all BEVACIZUMAB reports
70
Deaths
77
Hospitalizations
How Dangerous Is Hepatitis b reactivation From BEVACIZUMAB?
Of the 103 reports, 70 (68.0%) resulted in death, 77 (74.8%) required hospitalization.
Is Hepatitis b reactivation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 103 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Hepatitis b reactivation?
RITUXIMAB (914)
CYCLOPHOSPHAMIDE (801)
DOXORUBICIN (684)
VINCRISTINE (641)
PREDNISONE (583)
PREDNISOLONE (465)
LAMIVUDINE (308)
METHOTREXATE (305)
DEXAMETHASONE (293)
ETOPOSIDE (213)
Which BEVACIZUMAB Alternatives Have Lower Hepatitis b reactivation Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ